Caris Life Sciences and MiBA have formed a strategic partnership to enhance precision oncology. By combining Caris’ molecular profiling with MiBA’s real-world data and education tools, the collaboration aims to support oncologists, improve patient care, and advance cancer research.
IRVING, Texas & TAMPA, Florida – Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer, today anno ...